Global Tofacitinib Market Report 2023: Market to Reach $4.4 Billion in 2027 – Pfizer’s XELJANZ Granted FDA Approval for Treating Five Immuno-Inflammatory Diseases

DUBLIN, Oct. 18, 2023 /PRNewswire/ — The “Tofacitinib Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. The global tofacitinib market is expected to grow from $2.43 billion in 2022 to $2.76 billion in 2023 at a compound annual growth rate (CAGR) of 13….